Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT03450655
Other study ID # VCC-LIFE-4
Secondary ID
Status Enrolling by invitation
Phase N/A
First received February 16, 2018
Last updated February 28, 2018
Start date February 9, 2018
Est. completion date September 28, 2018

Study information

Verified date February 2018
Source Västerbotten County Council
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Given the increasing prevalence of obesity, there is an urgent need to find better strategies to promote physical activity in the community. The present study will invite 70-year-olds with central (abdominal) obesity to participate in a 10-week aerobic exercise program. Participants will be randomly assigned to one of two equally large groups. The first group will complete the exercise program in instructor-led groups. The second group will complete the program at home with the help of an on-line video.


Description:

Central obesity means having a lot visceral fat, that is, fat located in the abdominal cavity. Visceral fat is a well-established risk factor for cardiovascular disease and all-cause mortality.

Participants will be recruited from the Healthy Ageing Initiative (HAI), an ongoing population-based study that invites all 70-year-olds in Umeå, Sweden, to a health examination. The exercise program will focus is on station-based aerobic exercises and resistance exercises, predominantly with participants' own body weight as resistance. The program is progressive, starting at a moderate pace so that participants learn to perform the exercises properly. The intensity will be aimed at 60-80% of maximal exhaustion, and each exercise bout will last 60 seconds with 20 seconds of rest between bouts. The program was developed by seniors in the bachelor's program in exercise physiology at Umeå University, Sweden.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 80
Est. completion date September 28, 2018
Est. primary completion date September 28, 2018
Accepts healthy volunteers No
Gender All
Age group 70 Years to 70 Years
Eligibility Inclusion Criteria:

- Participated in the Healthy Ageing Initiative (a population-based intervention study in Umeå, Sweden)

- Visceral adipose tissue mass >1 kg (women) or >2 kg (men)

Exclusion Criteria:

- Physical disability that affects ability to perform the exercises

- Heart failure or severe degenerative condition (e.g. malignant cancer or multiple sclerosis)

- Myocardial infarction or stroke in the past year

- Heart condition that can worsen with aerobic exercise (e.g. angina)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
10-week aerobic exercise program
An aerobic exercise program consisting of 45-60 minute sessions 3 times a week for 10 weeks.

Locations

Country Name City State
Sweden Livsmedicin (LIFE) Umeå Västerbotten

Sponsors (2)

Lead Sponsor Collaborator
Västerbotten County Council Umeå University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in visceral adipose tissue mass Mass (g) measured using Lunar iDXA with CoreScan application (GE Healthcare, Wauwatosa, WI, USA). 0, 10, 20, and 31 weeks
Secondary Change in body composition Mass (g) measured using Lunar iDXA with CoreScan application (GE Healthcare, Wauwatosa, WI, USA) 0, 10, 20, and 31 weeks
Secondary Change in Body Mass Index (kg/m^2) 0, 10, 20, and 31 weeks
Secondary Change in blood pressure (mmHg) Taken after 15 min of rest 0, 10, 20, and 31 weeks
Secondary Change in blood-lipid profile 0, 10, 20, and 31 weeks
Secondary Change in fasting blood glucose Veinous blood samples taken after > 4 h of fasting 0, 10, 20, and 31 weeks
Secondary Change in isometric muscle strength Measured in non-dominant hand with dynamometer (Jamar, Lafayette Instrument, USA). The better of two successive trials will be recorded. 0, 10, 20, and 31 weeks
Secondary Change in physical capacity Measured using Åstrands Submaximal Test, performed on an electrically braked ergometer bicycle 0, 10, 20, and 31 weeks
Secondary Change in resting metabolic rate As measured by indirect calorimetry 0, 10, 20, and 31 weeks
Secondary Change in health-related quality of life As measured by RAND-36 0, 10, 20, and 31 weeks
Secondary Change in self-reported physical activity Assessed using IPAQ-SF 0, 10, 20, and 31 weeks
Secondary Change in Microbiota composition Fecal samples are taken and bacterial DNA is sequenced to determine bacterial composition 0, 10, 20, and 31 weeks
Secondary Change in dietary habits 85 item food frequency questionnaire 0, 10, 20, and 31 weeks
Secondary Change in concentration of inflammatory markers 0, 10, 20, and 31 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05147909 - Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity N/A
Completed NCT05463237 - Comparison of Visceral Adipokines Visfatin, Vaspin and Omentin Levels in Gestational Diabetes Mellitus Pregnant Women
Completed NCT04317079 - Effects of Hydroxytyrosol Administration in Anthropometric Parameters in Overweight and Obese Women N/A
Completed NCT04807959 - Evaluation of the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program
Recruiting NCT03363542 - The Effects of Increased Fiber Diet Consumption on Outcomes of Subjects With Visceral Obesity N/A
Completed NCT04691258 - Back Squat Exercise Treatment for Low Back Pain: Clinical Trial N/A
Completed NCT04638504 - Comparison of Brachial Artery Dilatation, Uterine Artery Doppler, Umbilical Artery Doppler and 1st-trimester Visceral Adipose Tissue Measurement in Obese and Normal Pregnant Women
Completed NCT04293731 - Smectite Gel and Probiotic for Obesity and Insulin Resistance N/A
Completed NCT04223557 - A Cholesterol Lowering Therapy of Focused Power Ultrasound Mediated Perirenal Fat Ablation N/A
Not yet recruiting NCT06377631 - Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity N/A
Completed NCT02449148 - Nutrition and Energy Restriction for Cancer Prevention N/A
Completed NCT03521817 - The Effects of Alcohol Consumption on Central Adiposity N/A
Completed NCT05807204 - Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal Obesity N/A
Recruiting NCT03592732 - The Role of Adipokines In Atrial Fibrillation
Recruiting NCT01447745 - Abdominal Fat and Imaging Measurements of Heart Disease N/A
Not yet recruiting NCT01560598 - Adipokines and the Risk of Reflux Esophagitis N/A
Recruiting NCT00431587 - Changes in Different Fat Compartments and Their Effect on Particular Manifestations of Metabolic Syndrome After Bariatric Procedures. N/A
Completed NCT03577834 - The Effect of Vinegar Consumption on Visceral Fat and Blood Glucose Concentration N/A
Completed NCT03506581 - Dysfunctional Adiposity and Glucose Impairment
Completed NCT01620697 - Visceral Obesity and Colorectal Surgery N/A